CoChat
Sign Up
Cited by 38

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Herbal medicines: challenges in the modern world. Part 4. Canada and United States

Job, Kathleen M., Kiang, Tony K. L., Constance, Jonathan E., Sherwin, Catherine M. T., Enioutina, Elena Yu.·2016·Expert Review of Clinical Pharmacology
DOI 10.1080/17512433.2016.1238762
Open this paper in CoChat — free account

Abstract

Introduction Similar to other nations North American people used herbs for thousands of years to treat diseases and purify their spirits. By the middle of the 1900s, evidence-based conventional medicine received wide acceptance in Canada and the United States (US). Nowadays, people are going back to their roots and actively using herbal medicines (HMs) and natural health products (NHPs). Areas covered: This article is focusing on use and regulation of the HMs and NHPs in Canada and the US, raises concerns regarding HM and NHP safety and efficacy, offers suggestions on how to overcome these problems. Materials available from legislative and governmental websites, PubMed and news media were used. Expert commentary: Use of HMs, especially dietary supplements is widespread among adults in Canada and US. HMs and NHPs are regulated in both countries, but minimum criteria for product approval and post-market surveillance have been set. Concerns of quality, contamination, adulteration, and efficacy in are of central importance in the discussion of HMs and NHPs. Detailed product description and research are of vital importance to ensure safety and efficacy of these products. Additionally, 'herbal' education of healthcare providers and patients is needed to guarantee further successful integration of HM and conventional medicines.

Overview

Integrity signals

Registry

Crossref · 10.1080/17512433.2016.1238762

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 58

  1. 10.1007/s11606-008-0632-y · DOI · Paper page
  2. 10.1001/jamainternmed.2013.2299 · DOI · Paper page
  3. 10.1016/j.sapharm.2009.02.004 · DOI
  4. 10.5688/aj740345 · DOI
  5. 10.1016/j.healthpol.2013.02.011 · DOI
  6. 10.1016/j.jep.2012.01.051 · DOI
  7. 10.1038/ki.2008.129 · DOI
  8. 10.3390/ijms17030331 · DOI
  9. 10.1186/1741-7015-11-222 · DOI
  10. Ventola CL, 2010, P T, 35, 461
  11. 10.1016/j.mam.2005.07.008 · DOI
  12. 10.1093/ecam/nek021 · DOI
  13. 10.1093/ecam/neh072 · DOI
  14. 10.1358/dnp.2003.16.3.829293 · DOI
  15. Borchers AT, 2000, Am J Clin Nutr, 72, 339, 10.1093/ajcn/72.2.339 · DOI
  16. Yang Y, 2015, Oxid Med Cell Longev, 619560, 2015
  17. 10.1016/j.jacr.2008.09.012 · DOI
  18. Ventola CL, 2010, P T, 35, 570
  19. Young AL, 1995, Food Drug Law J, 50, 285
  20. Clarke TC, 2015, Natl Health Stat Rep, 79, 1
  21. 10.1002/jcph.517 · DOI
  22. 10.1542/peds.2008-2173 · DOI
  23. Gahche J, 2011, NCHS Data Brief, 61, 1
  24. 10.1016/j.ctim.2013.05.001 · DOI
  25. Peregoy JA, 2014, NCHS Data Brief, 146, 1
  26. Black LI, 2015, Natl Health Stat Rep, 78, 1
  27. Stussman BJ, 2015, Natl Health Stat Rep, 85, 1
  28. 10.7453/gahmj.2014.019 · DOI
  29. 10.3945/jn.113.189803 · DOI
  30. 10.1177/0884533614528007 · DOI
  31. Nahin RL, 2009, Natl Health Stat Rep, 18, 1
  32. 10.1542/peds.2008-2173 · DOI
  33. 10.3945/jn.115.211102 · DOI
  34. 10.1002/dta.1980 · DOI
  35. 10.1093/toxsci/kfr198 · DOI
  36. Japsen B, 1995, Mod Healthc, 25, 138, 140, 142
  37. Food and Drug Administration H, 2016, Fed Regist, 81, 34165
  38. 10.1038/clpt.2009.263 · DOI
  39. Food and Drug Administration H, 2004, Fed Regist, 69, 31659
  40. 10.1080/01635581.2010.509833 · DOI
  41. 10.1111/j.1467-789X.2005.00169.x · DOI
  42. 10.1002/dta.1892 · DOI
  43. 10.1002/dta.1793 · DOI
  44. 10.1007/s00216-014-8159-z · DOI
  45. 10.1016/j.aca.2013.12.006 · DOI
  46. 10.1080/19440049.2014.892215 · DOI
  47. 10.1021/jf401139u · DOI
  48. 10.1016/j.pec.2014.12.010 · DOI
  49. 10.1345/aph.1Q710 · DOI
  50. 10.1016/j.tips.2013.09.003 · DOI
  51. Chow G, 2016, R I Med J (2013), 99, 16
  52. 10.1097/ACM.0000000000001173 · DOI
  53. 10.1016/j.explore.2005.12.003 · DOI
  54. 10.1186/1472-6882-9-11 · DOI
  55. 10.1136/bmjopen-2013-003431 · DOI
  56. 10.1371/journal.pone.0045196 · DOI
  57. 10.1016/j.ctim.2015.04.002 · DOI
  58. 10.1055/s-0042-111208 · DOI

Cited by

Sorted by citations

Metadata

Authors
Job, K. M., Kiang, T. K. L., Constance, J. E., Sherwin, C. M. T., & Enioutina, E. Y.
Venue
Expert Review of Clinical Pharmacology
Publisher
Informa UK Limited
Published
2016-10-03
Volume
9
Issue
12
Pages
1597-1609
ISSN
  • 1751-2433
  • 1751-2441
DOI
10.1080/17512433.2016.1238762
Cited by
38
References
2
Language
en
Funders
None

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review